Low IMA Ligation Did Not Significantly Reduce Leaks
-
By
-
Andrea Surnit
-
July 15, 2026
-
5 min
By
Andrea Surnit
July 15, 2026
Phase 3 findings showed longer median progression-free survival with zanidatamab-containing regimens vs trastuzumab plus chemotherapy.
August 25, 2026
Severe social jet lag among surgeons was associated with higher rates of major adverse events, independent of sleep duration, workload, and patient risk.
June 3, 2026